Your session is about to expire
← Back to Search
Dose Expansion for Gastric Cancer
Study Summary
This trial aims to first determine the highest safe dose of NKT3447 for adults with advanced solid tumors. Once that is found, the trial will then test the safety and effectiveness of NKT344
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the safety considerations of increasing medication dosage for individuals?
"Due to the limited amount of data supporting safety and efficacy, our team at Power rates Dose Escalation with a score of 1 on the scale from 1 to 3. This is in line with it being a Phase 1 trial."
Are there any vacancies available for patients to participate in this trial?
"The clinical trial, listed on clinicaltrials.gov as of February 1st, 2024 and updated most recently on February 9th, 2024, is presently not seeking participants. Despite this trial being closed for recruitment, there are currently a substantial number of 8989 other trials actively enrolling candidates."
Share this study with friends
Copy Link
Messenger